Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Hank Payments Achieves Record Growth in its Profitable Auto Channel (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News ACADIA Pharmaceuticals Inc ACAD

Healthcare Biotechnology
Acadia Pharmaceuticals Inc. is a biopharmaceutical company. The Company is focused on the development and commercialization of medicines that address unmet medical needs in central nervous system (CNS) disorders and rare diseases. It has a portfolio of commercial stage products, in-development product opportunities, and research programs that are designed to address unmet needs in CNS disorders... see more

Recent & Breaking News (NDAQ:ACAD)

Deadline in Lawsuit for Investors in ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) Shares Announced by Shareholders Foundation

GlobeNewswire March 18, 2015

SHAREHOLDER ALERT: Brower Piven Encourages Investors Who Have Losses in Excess of $100,000 From Investment in ACADIA Pharmaceuticals Inc. to Contact Brower Piven Before the Lead Plaintiff Deadline in Class Action Lawsuit -- ACAD

GlobeNewswire March 17, 2015

Rigrodsky & Long, P.A. Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against ACADIA Pharmaceuticals Inc.

PR Newswire March 17, 2015

Morgan & Morgan Announces That a Class Action Lawsuit Was Filed Against ACADIA Pharmaceuticals Inc. -- ACAD

GlobeNewswire March 17, 2015

ACADIA SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Reminds Investors With Losses in Excess of $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against ACADIA Pharmaceuticals Inc. -- ACAD

GlobeNewswire March 16, 2015

SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against ACADIA Pharmaceuticals Inc. and Certain Officers -- ACAD

GlobeNewswire March 16, 2015

INVESTOR ALERT: Investigation of ACADIA Pharmaceuticals Inc. Announced by Glancy Binkow & Goldberg LLP

Business Wire March 16, 2015

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of ACADIA PHARMACEUTICALS INC. of PENDENCY OF CLASS ACTION Lawsuit and a Lead Plaintiff DEADLINE of May 12, 2015 -- ACAD

GlobeNewswire March 16, 2015

Acadia Pharmaceuticals Inc. Investors Encouraged to Contact Securities Law Firm about Investigation into Allegations of Corporate Wrongdoing

PR Newswire March 16, 2015

Robbins Geller Rudman & Dowd LLP Files Class Action Suit against ACADIA Pharmaceuticals Inc.

Business Wire March 13, 2015

Robbins Arroyo LLP Is Investigating the Officers and Directors of ACADIA Pharmaceuticals Inc. (ACAD) on Behalf of Shareholders

PR Newswire March 13, 2015

INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses In Excess Of $100,000 Investing In Acadia Pharmaceuticals, Inc. (ACAD) To Contact The Firm

PR Newswire March 13, 2015

Harwood Feffer LLP Announces Investigation of Acadia Pharmaceuticals Inc.

PR Newswire March 12, 2015

ACAD SHAREHOLDER ALERT: The Law Firm of Levi & Korsinsky, LLP Launches an Investigation into Possible Violations of Federal Securities Laws by Acadia Pharmaceuticals Inc.

Business Wire March 12, 2015

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ACADIA Pharmaceuticals Inc. - ACAD

PR Newswire March 12, 2015

SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Acadia Pharmaceuticals Inc.

PR Newswire March 12, 2015

ACADIA SHAREHOLDER ALERT: Shareholder Rights Law Firm Johnson & Weaver, LLP Announces Investigation of ACADIA Pharmaceuticals Inc.

Business Wire March 11, 2015

ACADIA Pharmaceuticals Announces Retirement of Uli Hacksell, Ph.D., Chief Executive Officer

Business Wire March 11, 2015

ACADIA Pharmaceuticals Updates Planned Timing of NUPLAZIDTM NDA Submission

Business Wire March 11, 2015

ACADIA Pharmaceuticals Reports Financial Results for the Fourth Quarter and Year Ended December 31, 2014

Business Wire February 26, 2015